Target intelligence / Profile preview

Corneal epithelial basement membrane

Molecular classification
Other
01

Overview

The corneal epithelial basement membrane is a specialized extracellular matrix between basal epithelial cells and the corneal stroma, composed principally of collagens, laminins, heparan sulfate proteoglycans (e.g., perlecan), and nidogens, with other components such as thrombospondin-1, matrilin-2/4, and sometimes fibronectin[1][3]. It anchors epithelium to stroma, supports epithelial migration and differentiation, and functions as a selective barrier and growth-factor reservoir that shapes homeostasis and wound healing[1][3]. Defective regeneration after injury allows epithelial- and tear-derived TGF-β and PDGF to persist in the stroma, driving myofibroblast development and corneal fibrosis/haze until the BM is fully restored and profibrotic signaling abates[3]. An intact BM also limits microbial translocation; disruption by injury or bacterial proteases facilitates penetration in infections such as Pseudomonas keratitis[4]. Epithelial reattachment involves reassembly of hemidesmosomes and anchoring fibrils; if the BM is damaged, firm adhesion can take months to re-establish[2].

Other names
Corneal epithelial basement membrane (EBM)Corneal basement membraneEpithelial basement membrane of the corneaOcular surface epithelial basement membraneBasement membrane of corneal epithelium
02

Mechanism of action

Restoration of BM integrity reduces stromal penetration of TGF-β/PDGF, depriving myofibroblasts of profibrotic cues and promoting apoptosis, which clears haze[3] Maintaining an intact BM provides a physical size-exclusion and matrix barrier that reduces microbial translocation across epithelium[4]

03

Biological functions

Structural anchoring of epithelium to stroma via hemidesmosomes and extracellular matrix components[1][2][3]Barrier and reservoir/modulator for growth factors (e.g., TGF-β, PDGF), regulating development, homeostasis, and wound repair[1][3]Regulation of epithelial migration, differentiation, and re-epithelialization after injury[1][2][3]Anti-infective physical barrier limiting microbial penetration when intact[4]
04

Disease associations

Fibrosis/haze following injury or surgery when basement membrane regeneration is defective, enabling sustained stromal exposure to TGF-β/PDGF and myofibroblast persistence[3]Ocular surface infection susceptibility when the basement membrane is disrupted[4]Corneal wound-healing disorders and recurrent erosions related to impaired epithelial adhesion and BM integrity[2][3]
05

Safety considerations

Therapeutic challenge: severe epithelial/BM damage can take months or longer to re-establish firm epithelial-stromal adhesion, prolonging risk of erosions and haze[2][3]Disrupted BM permits excess stromal exposure to cytokines, sustaining fibrosis and delaying visual recovery[3]Infection risk increases when BM is breached; bacterial proteases (e.g., from Pseudomonas aeruginosa) can degrade BM components and enhance penetration[4]
06

Interacting drugs

Topical corticosteroids (indirectly modulate TGF-β signaling and inflammation during corneal wound healing; not a direct binder of the BM)[3]

2 more in the full profile.

07

Biomarkers

Presence/absence of key BM components (e.g., laminins, nidogen-1/2, perlecan) indicating BM regeneration status in healing cornea[3]Clinical haze/opacity and myofibroblast markers (vimentin, α-SMA, desmin) reflecting profibrotic signaling due to BM defects[3]

Beyond the preview

Go deeper on Corneal epithelial basement membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal epithelial basement membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call